Where the Next Billion-Dollar Food Brands Get Built

Five structural forces are converging on food and beverage right now. Any one of them builds category-defining brands. Together they are triggering the largest redistribution of category value the industry has seen in three decades, and the brands capturing it now are becoming the next Fairlife, the next Chobani, the next category-defining platform.

The operators and investors who move are building those brands. The ones who wait are watching from the outside.

If you are testing a specific product, platform, acquisition target, or capacity commitment that needs to be stress-tested against the convergence now taking shape act now.

The Helmsman Group engages a selective number of manufacturers, cooperatives, and investors each quarter on UPF Exposure Assessments. Each assessment stress-tests a specific product, platform, or capacity commitment against the current NOVA framework, the emerging federal UPF definition, and the scenarios between them.

The deliverable is a formal document built for internal strategic planning, capital committee diligence, or board-level discussion.

If this is relevant to what you are navigating, contact us

Five structural forces are converging on food and beverage. Any one of them builds category-defining brands. Together they are redistributing billions of dollars of category value from operators who hesitate to operators who move. What follows is the argument in compressed form.

The category-defining food brands of the last fifteen years were not anomalies. Fairlife went from novelty to a $650 million Coca-Cola facility investment. Chobani crossed two billion in annual revenue. Oatly IPO'd at a ten billion dollar valuation. Liquid Death passed one point four billion. RXBAR sold to Kellogg for six hundred million. Each one of those outcomes traces back to a moment when a category was being repriced and someone positioned inside the shift while everyone else debated whether the shift was real.

The convergence unfolding right now is the mechanism by which the next wave of those brands, and the category consolidators, platforms, and carve-outs that feed them, is being built. The question is not whether the shift is real. The question is who recognizes it in time to position inside it and who has the capital, the regulatory architecture, and the process capability to move when positioning requires moving.

Those brands are the outcomes. The pattern that produces them is what this paper maps. I did not learn the pattern from a report. I learned it in my own pilot plant in Portland, on a client project, in real time.

About two and a half years ago The Helmsman Group took on a shelf stable high protein dairy beverage for a client. A clear brief. A defined channel. The kind of development work we have executed hundreds of times across more than five hundred brands.

Then the ground shifted.

This ambiguity didn't just create compliance confusion. It created a lucrative business model for plaintiff attorneys:

The economics are brutal. For a venture-backed alternative protein company, spending $1.5 million on legal defense (even if your interpretation is reasonable) can be existentially threatening. Settlement becomes the rational choice.

The plaintiff attorneys know this. They're pursuing these cases because regulatory ambiguity creates enough uncertainty that companies will pay to avoid the risk.

This is a shakedown enabled by ambiguous regulatory triggers that plaintiff attorneys exploit systematically.

The full technical and financial architecture behind this piece is available as a complete white paper covering all six forces, the five-layer financial exposure model, the cash consequence timeline, and the decision framework used to position.

The consumer data moved first. GLP-1 adoption outran every projection and the brief stopped being "high protein shelf stable dairy beverage" and became "complete nutrition in eight ounces that does not cause GI distress in someone whose appetite has been cut by a third." The thermal process had to be re-engineered.

Then the regulatory environment moved. FDA and USDA opened a joint rulemaking on ultra-processed foods (UPF) and functional ingredients doing real nutritional work were suddenly at risk of classification as UPF inputs. The formulation was reworked.

Then retailer standards moved. A major retail partner flagged two ingredients under supplier requirements that did not exist when the project began. Another rework.

Then tariffs re-escalated. A key ingredient's landed cost jumped overnight and the margin model broke.

Then EPR packaging programs in three states forced a container redesign, which forced a thermal revalidation.

Standing in the pilot plant watching a talented team hold together a project where the goalposts had shifted five times in eighteen months revealed something important. The original challenge was hard but solvable. What it had become was something else.

It was not incrementally harder. It had become a fundamentally different class of problem.

That was one project. Eighteen months. Five goalpost shifts. The forces that reshaped it have not slowed since. They have accelerated. The next eight months sit at the peak of that acceleration, and the convergence that reshaped one product in a pilot plant is now the operating condition of every product in every category.

GLP-1 is the satiety economy repricing demand across every protein-dense category. Ultra-filtration (UF) and aseptic processing is the platform behind the billion-dollar brands the last decade produced, Fairlife is the template, and the foundational patent wall just fell, opening the category to anyone with the capital and the process engineering to build. Fiber is the pharmacologically urgent macronutrient that fortifies products for thirty million consumers whose GI systems have been altered by medication. Ultra-processed foods (UPF) is the regulatory and retailer motion that decides which ingredients survive the compression ahead. Hidden taxes and the litigation economy is the compounding EPR, tariff, and plaintiff-bar pressure that shows up in working capital before it shows up in P&L.

UF is the flood gate. UPF is the constraint. Fiber and GLP-1 are the demand. Hidden taxes and litigation are the friction. Getting this sequence right is the difference between positioning for the opportunity and absorbing the downside while missing the upside.

Any one of these forces managed well generates durable advantage. The trouble is the interactions.

GLP-1 reformulation triggers UPF classification exposure. UPF exposure triggers color additive exposure. Color exposure triggers retailer procurement events. Retailer events trigger EPR revalidation. EPR and tariffs trigger sourcing cascades. All of it triggers litigation surface.

The interactions between the five forces generate a combinatorial complexity problem that no human team can optimize across simultaneously at the speed this market now demands. That observation is where the sixth force enters.

Five external forces. A sixth force that decides whether you capture the value they create or get crushed by their complexity. Artificial intelligence deployed as transformational infrastructure.

The leaders of Anthropic, OpenAI, and Microsoft are on public record forecasting civilizational scale AI capability on a thirty-six month horizon. The combinatorial complexity that the first five forces create exceeds human cognitive bandwidth. The operators who integrate AI into formulation, compliance, quality, and supply chain now are accumulating the learning, data integration, and workflow optimization that late movers cannot purchase by writing a larger check.

That gap is opening right now. Every quarter an operator delays building the infrastructure is another quarter of compounding disadvantage against the operators who did not delay. The gap is moving from wide to unbridgeable.

January 1, 2027 is eight months away. It concentrates the largest single cluster of cash events the food and beverage industry has faced in a generation.

California SB 54 begins drawing five hundred million dollars annually from CPG companies. Medicare negotiated GLP-1 pricing takes effect the same day. Novo Nordisk list price reductions for Wegovy, Ozempic, and Rybelsus take effect the same day. Texas SB 25 warning label requirements become effective January 1. Maine's EPR program launches. Multiple industry pledge deadlines for synthetic color elimination hit through 2027.

An operator making capital allocation decisions this quarter is making decisions against a deadline. An operator starting this work after the first of next year is responding to consequences already materializing.

For a mid-tier processor in the one hundred to five hundred million dollar revenue range, the spread between favorable and adverse positioning runs between five and fifteen points of revenue. Across the mid-tier segment of the industry, that spread translates to billions of dollars of category value moving from operators who hesitated to operators who positioned. That redistribution is already underway.

The billion-dollar brands forming now are being built on the favorable side of that spread. The cautionary tales are being built on the other side. The sorting is happening this quarter.

A map is not the territory. The operators and investors capturing the biggest wins of this moment are not the ones reading the fastest. They are the ones who hire the pilots who have been navigating these waters for thirty-five years, and who deploy the regulatory, formulation, process engineering, and AI-native instruments to keep the ship on course when the weather turns.

That is what The Helmsman Group does. It is what RegulateCPG does as the AI-powered compliance and intelligence layer deployed across every engagement. The full technical and financial architecture behind this piece is published as a forty-page white paper covering each of the six forces, the five-layer financial exposure model, the cash consequence timeline, and the six-diagnostic decision framework that operators and capital allocators use to position. It is available here for readers who want the complete reference. But the paper is the chart. The engagement is where the chart becomes a route, and the route is where the returns live.

This moment does not reward hesitation. It does not reward the unwilling to deploy capital. The operators and investors who read this framework and move this quarter are the ones building the category-defining brands now taking shape. The ones who read and wait will read about those outcomes from the outside.

The window is now. There is no other.

If you are the decision-maker weighing a category-defining move and need a confidential, principal-level conversation, not a deliverable.

A small number of CEOs, boards, and investment committees each quarter engage directly on regulatory architecture, classification strategy, capital deployment, and platform positioning across UF and aseptic categories.

These engagements begin with a confidential conversation.

Mark Haas is the founder and CEO of The Helmsman Group, a Portland-based food science, process engineering, and regulatory consulting firm, and co-founder of RegulateCPG, an AI-powered compliance infrastructure platform for the food and beverage industry. With 35 years of experience and more than 500 brands formulated, Mark is one of roughly 100 Process Authorities recognized by AFDO, with aseptic processing specialization. He partners with NVIDIA, Microsoft, and AWS to build AI infrastructure for food and beverage compliance.
For more insights on the forces reshaping this industry, visit regulatecpg.com or connect with Mark on LinkedIn.

Legal Disclaimer: This article discusses regulatory strategy and industry dynamics but does not constitute legal advice. Companies should consult qualified food law attorneys and regulatory counsel for guidance on specific classification and compliance questions applicable to their products.